Innovative leader in drug discovery space with a track record of conceiving and executing strategies for the treatment of metabolic syndrome using small molecules and biologics (peptides, protein domains, antibodies, fusion proteins) targeting GPCRs, nuclear receptors and circulating factors. Broad and demonstrated hands-on in vitro, ex vivo and in vivo expertise in key areas of metabolism including beta cell function, insulin sensitization, hypothalamic signaling and liver metabolism. Forward looking "out of the box" thinking entrepreneur, mentor and pharmacologist with the tools and leadership qualities necessary to take ideas from conception into clinical development.Specialties: Drug Discovery, Diabetes, Islet and Adipocyte biology, Cardiovascular & Metabolism, Neuroscience, Neurodegenerative Diseases, Alzheimer's, Molecular and Cell Biology, Pharmacology